{"log_id": 54693269635094127, "direction": 0, "words_result_num": 52, "words_result": [{"probability": {"variance": 0.020141, "average": 0.921095, "min": 0.474298}, "location": {"width": 1102, "top": 212, "height": 43, "left": 267}, "words": "cYP2c19基因强代谢型人群单剂星静脉注封1C标记的泮托拉唑钠后,约71%的剂量从"}, {"probability": {"variance": 0.00905, "average": 0.969006, "min": 0.467378}, "location": {"width": 916, "top": 253, "height": 36, "left": 208}, "words": "尿中排以及18%通过胆汁挂泄由炎便排出,无泮托拉唑原型从肾脏排出"}, {"probability": {"variance": 0, "average": 0.999936, "min": 0.999926}, "location": {"width": 61, "top": 294, "height": 32, "left": 208}, "words": "老年"}, {"probability": {"variance": 0.02758, "average": 0.919221, "min": 0.367491}, "location": {"width": 1104, "top": 326, "height": 38, "left": 265}, "words": "老年人(65至76岁〕连续静脉给药后,汽托拉唑的由线下积和消除半衰期值与在年轻"}, {"probability": {"variance": 0.017069, "average": 0.921061, "min": 0.450958}, "location": {"width": 747, "top": 368, "height": 36, "left": 208}, "words": "受试者中观察到的相似,囚而对老年患者,不建议调整剂量"}, {"probability": {"variance": 0, "average": 0.996601, "min": 0.996148}, "location": {"width": 64, "top": 411, "height": 32, "left": 208}, "words": "性别"}, {"probability": {"variance": 0.017481, "average": 0.940471, "min": 0.410813}, "location": {"width": 1099, "top": 445, "height": 38, "left": 269}, "words": "1服给药后,女仨中吃泮托拉曲线下面积和血药峰浓度较男性有适度增加,但体调"}, {"probability": {"variance": 0.023242, "average": 0.937547, "min": 0.392538}, "location": {"width": 772, "top": 484, "height": 34, "left": 208}, "words": "整男和女的清除率相似,因而没必要就性别而调整剂量"}, {"probability": {"variance": 0.005331, "average": 0.953013, "min": 0.810812}, "location": {"width": 146, "top": 523, "height": 32, "left": 208}, "words": "肾功能不全"}, {"probability": {"variance": 0.010354, "average": 0.95511, "min": 0.607818}, "location": {"width": 1104, "top": 555, "height": 38, "left": 267}, "words": "严重肾力能不全患老的托拉唑药代动刀学参数与正常人类似。对肾功能衰竭患者或血"}, {"probability": {"variance": 0.044427, "average": 0.864011, "min": 0.351591}, "location": {"width": 374, "top": 594, "height": 36, "left": 208}, "words": "液透析的患者,无需调整剂"}, {"probability": {"variance": 6.9e-05, "average": 0.991651, "min": 0.976665}, "location": {"width": 148, "top": 635, "height": 32, "left": 205}, "words": "肝功能不全"}, {"probability": {"variance": 0.02498, "average": 0.919163, "min": 0.362137}, "location": {"width": 1106, "top": 667, "height": 41, "left": 265}, "words": "在轻度至重度肝功能不全患老(肝硬化者 Child-Pug分级A-C)口服托拉唑后,最"}, {"probability": {"variance": 0.022407, "average": 0.896958, "min": 0.475922}, "location": {"width": 1161, "top": 706, "height": 38, "left": 208}, "words": "高泮托拉唑浓度梧对于正常人仅略有增加1.5倍),尽管肝脏受的考的土清半衰期上升"}, {"probability": {"variance": 0.017754, "average": 0.938569, "min": 0.391608}, "location": {"width": 1166, "top": 747, "height": 36, "left": 205}, "words": "到7~9小时,曲线下面积值增加了5~7倍,但这些升井未LCYP2C19基因宾代谢且不需"}, {"probability": {"variance": 0.024516, "average": 0.914174, "min": 0.466235}, "location": {"width": 1163, "top": 784, "height": 38, "left": 208}, "words": "整剂量的人群大,肝脏受指患名的药代动力学变化在每日一次,多剂量给药时,很少导致"}, {"probability": {"variance": 0.025881, "average": 0.909318, "min": 0.378202}, "location": {"width": 1166, "top": 823, "height": 38, "left": 205}, "words": "积,因而轻度至重度肝功能不全患者无需调整剂量,高于4lmg/天的剂量在肝功能受损患"}, {"probability": {"variance": 0.036282, "average": 0.841456, "min": 0.471266}, "location": {"width": 173, "top": 866, "height": 32, "left": 208}, "words": "耆中尚未矸究"}, {"probability": {"variance": 0.000139, "average": 0.990378, "min": 0.965719}, "location": {"width": 180, "top": 905, "height": 32, "left": 208}, "words": "药物相互作用"}, {"probability": {"variance": 0.020436, "average": 0.918055, "min": 0.396351}, "location": {"width": 1104, "top": 932, "height": 43, "left": 265}, "words": "泮托拉主装由CYP2C19,少量庄CYPs3A4,2D6和2C9代谢,针对Y2C19底地"}, {"probability": {"variance": 0.015569, "average": 0.924565, "min": 0.460728}, "location": {"width": 1154, "top": 976, "height": 36, "left": 208}, "words": "西泮(CYP3A4的底物)和苯妥英CCYP3A诱导剂)1、硝苯地平咪唑安定、克拉季"}, {"probability": {"variance": 0.032319, "average": 0.882519, "min": 0.368157}, "location": {"width": 1127, "top": 1017, "height": 36, "left": 251}, "words": "YP3A4底物〕、美托洛尔(CYP2D底物)、双氯芬酸、萘普生、批罗昔康C￥P2底"}, {"probability": {"variance": 0.027731, "average": 0.893399, "min": 0.363917}, "location": {"width": 1163, "top": 1051, "height": 48, "left": 208}, "words": "物〕和茶碱( CYPIA2的底物〕,在健康受试孝中进行了体内药物相作用的研,洋拉"}, {"probability": {"variance": 1.7e-05, "average": 0.99772, "min": 0.987591}, "location": {"width": 441, "top": 1097, "height": 36, "left": 205}, "words": "的药代动力学性质没有显著改变"}, {"probability": {"variance": 0.02909, "average": 0.878919, "min": 0.405643}, "location": {"width": 1104, "top": 1127, "height": 43, "left": 267}, "words": "氯x:格雷部分由CYP2C19代谢支其活性代谢物。在一项交叉临床究中,66位健康"}, {"probability": {"variance": 0.034226, "average": 0.877524, "min": 0.375222}, "location": {"width": 1166, "top": 1172, "height": 36, "left": 208}, "words": "给予氯吡格雷(负荷剂量为300mg随后75mg天)并使用泮托拉唑(8me,与格雷"}, {"probability": {"variance": 0.001675, "average": 0.972912, "min": 0.827027}, "location": {"width": 1159, "top": 1207, "height": 36, "left": 210}, "words": "同时给药),连续5天:第五天时:将氯吡格雪与泮托拉唑合用时与单独使用氯格雷进行"}, {"probability": {"variance": 0.008618, "average": 0.965774, "min": 0.432824}, "location": {"width": 1161, "top": 1246, "height": 36, "left": 210}, "words": "比较,氯吡格雷活性代产物的平均由线下面积减少约14%(几何平均比率为86%190%洁"}, {"probability": {"variance": 0.008402, "average": 0.959505, "min": 0.514377}, "location": {"width": 1159, "top": 1284, "height": 36, "left": 208}, "words": "除率时为79%全93%)、药效学参数的测量表明乙抑制血小板聚集的改变(由5微摩尔A"}, {"probability": {"variance": 0.005911, "average": 0.970236, "min": 0.648346}, "location": {"width": 946, "top": 1323, "height": 38, "left": 210}, "words": "诱导)与氯吡格雪活性代谢产物的变化相关,这一发现的临床意义尚不清楚"}, {"probability": {"variance": 0.007396, "average": 0.969921, "min": 0.521704}, "location": {"width": 1108, "top": 1360, "height": 38, "left": 267}, "words": "体内研究还表明,泮托拉唑不显著影响其他药物的动力学[西沙必利、茶碱、地西严(和"}, {"probability": {"variance": 0.022175, "average": 0.915222, "min": 0.411501}, "location": {"width": 1166, "top": 1399, "height": 38, "left": 208}, "words": "其活性代谢产物、去甲基地开泮〕、华法林、苯妥英、关振洛尔、硝苯地平、卡马西、以"}, {"probability": {"variance": 0.03661, "average": 0.854232, "min": 0.352923}, "location": {"width": 1166, "top": 1435, "height": 38, "left": 210}, "words": "唑安定、克拉霉系、茶普生、岁昔康和口胀避孕药左诺孕酮雌醇],当它们与泮拉唑"}, {"probability": {"variance": 0.026879, "average": 0.901603, "min": 0.404306}, "location": {"width": 1220, "top": 1467, "height": 45, "left": 208}, "words": "联合用时,没有必要进行剂量调整。在其他体内的研究中,地高辛、乙醇、列本"}, {"probability": {"variance": 0.007175, "average": 0.958381, "min": 0.683284}, "location": {"width": 893, "top": 1515, "height": 36, "left": 210}, "words": "替比林、啡因、甲硝唑、阿莫丙林与泮托拉唑无临庆相关的互作月"}, {"probability": {"variance": 0.017749, "average": 0.941733, "min": 0.428324}, "location": {"width": 1113, "top": 1547, "height": 41, "left": 267}, "words": "评估可能与泮托拉心产生互作用的研究基础上,与下列药物合用时,不需要调整利"}, {"probability": {"variance": 0.015267, "average": 0.951854, "min": 0.364113}, "location": {"width": 1168, "top": 1584, "height": 48, "left": 212}, "words": "量:茶碱、西沙必对、安替比林、咖啡因、卡马西平、地西泮(和其活性代谢产物、甲基"}, {"probability": {"variance": 0.020588, "average": 0.923516, "min": 0.398853}, "location": {"width": 1168, "top": 1625, "height": 43, "left": 210}, "words": "地西泮)、双氯灭痛、地高辛、萘音生、吡罗芍康、乙醇、格列本、口1避孕药(左诺"}, {"probability": {"variance": 0.030036, "average": 0.895339, "min": 0.41384}, "location": {"width": 1172, "top": 1666, "height": 45, "left": 210}, "words": "孕快雌醇、雌二醇),美托洛尔、硝本地平、苯妥莫、华法林、咪安定、克拉霉"}, {"probability": {"variance": 0.003695, "average": 0.949357, "min": 0.848582}, "location": {"width": 205, "top": 1712, "height": 34, "left": 212}, "words": "硝、阿莫西林"}, {"probability": {"variance": 0, "average": 0.914825, "min": 0.914825}, "location": {"width": 29, "top": 1717, "height": 27, "left": 1310}, "words": "!"}, {"probability": {"variance": 0.00064, "average": 0.986135, "min": 0.903987}, "location": {"width": 379, "top": 1749, "height": 34, "left": 272}, "words": "与抑酸剂合用时也无相互作用"}, {"probability": {"variance": 0.022162, "average": 0.915465, "min": 0.473288}, "location": {"width": 1065, "top": 1783, "height": 36, "left": 274}, "words": "上市后报告表明患者使用包括注射月汽托拉唑钠并伴随华法(见【药物相互作用】"}, {"probability": {"variance": 0.023426, "average": 0.921917, "min": 0.393637}, "location": {"width": 631, "top": 1824, "height": 36, "left": 212}, "words": "在内的质子余制剂,其凝血酶原时间、INR高"}, {"probability": {"variance": 0.00291, "average": 0.973974, "min": 0.710792}, "location": {"width": 1106, "top": 1856, "height": 43, "left": 272}, "words": "虽然在临床研究中木观察到明显的药物相互作用,但对每天多次用高剂量的泮托拉唑"}, {"probability": {"variance": 0.004242, "average": 0.981329, "min": 0.664778}, "location": {"width": 724, "top": 1899, "height": 36, "left": 212}, "words": "的弱代谢或肝损伤病人,其潜在的药物相互作用尚末研究"}, {"probability": {"variance": 0.000194, "average": 0.99184, "min": 0.967719}, "location": {"width": 118, "top": 1938, "height": 36, "left": 272}, "words": "其他影响"}, {"probability": {"variance": 0.01283, "average": 0.948172, "min": 0.365399}, "location": {"width": 1079, "top": 1968, "height": 45, "left": 301}, "words": "项临床药理学研究表明,泮拉唑每日单剂量口服40mg2周对以下激素的水平无影"}, {"probability": {"variance": 0.031638, "average": 0.897347, "min": 0.456299}, "location": {"width": 1136, "top": 2007, "height": 41, "left": 217}, "words": "响:皮质醉、睾酮、甲状腺素(T)、甲状腺素(T4),促甲状腺激素、甲状腺素合蛋白"}, {"probability": {"variance": 0.031093, "average": 0.882241, "min": 0.456202}, "location": {"width": 1168, "top": 2046, "height": 38, "left": 212}, "words": "甲状旁脲激素、胰岛素、胰高血糖素,肾素、醛匠酮、促卵泡激素、促黄体激素、催乳蒸"}, {"probability": {"variance": 0.012131, "average": 0.940774, "min": 0.720693}, "location": {"width": 150, "top": 2087, "height": 32, "left": 212}, "words": "和生长激索"}, {"probability": {"variance": 0.009294, "average": 0.956444, "min": 0.740877}, "location": {"width": 180, "top": 2123, "height": 34, "left": 272}, "words": "药物基因组学"}], "language": 3}